Pharmaceutical Cost Transparency Act (S.5338A)
Resolution calling upon the New York State Legislature to pass and the Governor to sign the Pharmaceutical Cost Transparency Act (S.5338A), which would require prescription drug manufacturers to file an annual report disclosing certain financial information pertaining to high-cost prescription drugs
Status
Filed (End of Session)
File ID
Res 1100-2016
Introduced
6/8/2016
Committee
Committee on Health
Sponsors (2)
Bill History
Comments
Sign in or create an account to comment.
- Have something to say? Start the discussion.